Executive Summary: HIV: A Strategic Analysis of Therapeutic and Testing MarketsKalorama Information Executive SummariesMarch 1, 2006 16 Pages - SKU: KLE1285712 |
|
Global Vaccine Market Forecast to 2017
5/1/2013 | published by: RNCOS
Of late, the vaccines market is burgeoning with immense activities. Big pharmaceutical companies like GSK, Pfizer, Merck etc. are struggling to maintain their revenue and operating incomes amidst patent cliffs of blockbuster drugs. In such
|
read more...
|
$1,500.00
|
|
2013 Analysis of the Syphilis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/17/2013 | published by: Venture Planning Group
The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed.
|
read more...
|
$4,350.00
|
|
2013 Analysis of the Herpes Markers Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/17/2013 | published by: Venture Planning Group
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed.
|
read more...
|
$5,450.00
|
|
2013 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/17/2013 | published by: Venture Planning Group
2013 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape presents a detailed analysis of the AIDS diagnostics
|
read more...
|
$5,450.00
|
|
HIV / AIDS – Pipeline Review, H1 2013
2/28/2013 | published by: Global Markets Direct
HIV / AIDS – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,500.00
|
|
AIDS - Related Kaposi's Sarcoma – Pipeline Review, H1 2013
2/28/2013 | published by: Global Markets Direct
AIDS - Related Kaposi's Sarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on
|
read more...
|
$2,000.00
|
|
HIV-Associated Lipodystrophy Syndrome – Pipeline Review, H1 2013
2/28/2013 | published by: Global Markets Direct
HIV-Associated Lipodystrophy Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'HIV-Associated Lipodystrophy Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Genital Herpes Global Clinical Trials Review, H1, 2013
3/12/2013 | published by: GlobalData
Genital Herpes Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2013 provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data
|
read more...
|
$2,500.00
|
|
Herpes Simplex Infections – Pipeline Review, H1 2013
3/18/2013 | published by: Global Markets Direct
Herpes Simplex Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Herpes Simplex Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Competing in the Global Sexually-Transmitted Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players
2/22/2013 | published by: Venture Planning Group
This new 350-page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles
|
read more...
|
$9,600.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
AIDS, HIV & STDs Reports
- Global Vaccine Market Forecast to 2017
- 2013 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
- Herpes Simplex Infections Global Clinical Trials Review, H1, 2013
- Gonorrhea Global Clinical Trials Review, H1, 2013
- Herpes Simplex Infections – Pipeline Review, H1 2013